Money Map Report

Publisher: Money Map Press

Welcome! If you are new to Stock Gumshoe, grab a free membership here and join us to get our free newsletter alerts with new teaser answers and debunkings. Thanks!Not new? Please log in at top right of this page

Gumshoe Articles & Teaser Picks Revealed

The latest screed from Danielle O’Dell for the Money Map Report is aimed at first getting you all fired up about Obamacare, in case you’re one of the seven people in the United States that doesn’t already have a strong opinion about that law’s impending enactment, and then, more importantly, at telling you that she’s […]

Keith Fitz-Gerald and the folks at the Money Map Report are pitching something they call “Super Dividends” — payments that dwarf the typical dividend and that they say are even distinct from “special dividends.” But not content to promise big returns ($16,559 as soon as June 28, they say), they also claim that they can […]

Today’s tease comes in for the Money Map Report, in some articles where they hint around about the best way to double your money on the stock they think can be the “Next Whole Foods.” The pick is by Keith Fitz-Gerald, but We get a bit of an introduction from Steve Christ in a free […]

“Why I’m Ready to Place a $2,450 “Bet” on Your Behalf… “Given what we’ve learned about one tiny drug company – and the documented 82% success rate within the category of drug it’s developed – we think this is the “surest thing” we’ve ever found… “How this ‘wager’ could make you thousands of dollars (or […]

The good folks over at the Money Map Press are selling memberships in their “Passport Club” this week, and your impetus for signing up is that they will reveal their top-secret obesity drug that they think will be approved in about a week. The Passport Club, by the way, is one of those “lifetime” offers […]

Subscriber Reviews

I cancelled this after the first to issues. It’s just random stock picking, hardly any thought given nor any explanation or rationale. It’s not worth using for toilet paper, IMHO. I did get my money back.

After reading prior reviews, nearly all reflect my opinions. This note is intended to add a bit of color based on my experience.

Subscribed for 2 years, $49/yr. Main positive is the rare occasions when Keith provides reviews. Others seem to believe they’re the world’s greatest marketeers. Getting off their mailing list for “other” publications which are 99% horse apples is difficult if not impossible (quantity vastly exceeds quality). They use deceptive verbiage constantly that is reminiscent of a Harvard MBA marketing grad with no experience but with ample confidence in his ability to attract foolish investors. (Not all Harvard grads share this “feature”, but a growing number are winding up on Wall Street. Another disaster is in our future.)

Most gains for selections on their list are based on buy prices that are rarely obtainable. One might reasonably conclude that most buys are picks from their other far more expensive newsletters ($600-$3000/yr) but including a time delay. Several checks on charts proved this to my satisfaction.

In a single week I’ve found GS to be far more useful than 2 yrs of MMR.

Articles by contributors are mainly come-ons for their more expensive newsletters and do not appreciate being criticized for this trait.

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions.

Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies.

Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.